Stay updated on Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page
- Check5 days agoChange DetectedAdded a Publications section noting a 2025 Dermatol Ther article and PubMed auto-listing. Removed the funding lapse notice about government funding affecting site updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Study Details page appears unchanged between screenshots. Core information such as the title, identifier (NCT04417894), study design, eligibility criteria, and locations remains the same.SummaryDifference0.3%

- Check48 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check55 days agoChange DetectedApp page now shows Revision: v3.1.0 and removes several MedlinePlus drug safety topics, reducing related content coverage.SummaryDifference0.4%

- Check69 days agoChange DetectedUpdated to Revision: v3.0.2 (from v3.0.1) and removed the Back to Top element. This appears to be a routine release update with minor UI cleanup.SummaryDifference0.2%

- Check76 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

Stay in the know with updates to Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.